Tuesday, March 12, 2013

Health News: [diabetes ]

Yahoo! Health - My Alerts - Edit Alert
Tuesday, Mar 12, 2013 04:11 PM EDT
Mark March 26 as day to assess your diabetes risk in event at UAB
Tue, 12 Mar, 2013 11:51 AM PDT
  BIRMINGHAM, Alabama -- Learn about your risks for diabetes on campus at UAB on March 26 in an event sponsored by the American Diabetes Association.It's called Alert Day and is billed as a one-day "wake-up call" to challenge...
Encouraging Data Presented by Gilead - Analyst Blog
Tue, 12 Mar, 2013 11:39 AM PDT
Gilead Sciences, Inc. ( GILD ) recently presented encouraging data on its chronic angina drug Ranexa (ranolazine) from a phase IV study (TERISA: n=927). The TERISA (Type 2 Diabetes
Investigating diabetes, obesity and high blood pressure
fuseworks.co.nz Tue, 12 Mar, 2013 11:21 AM PDT
The University of Canterbury (UC) is this year looking to investigate the risk factors of diabetes, obesity and high blood pressure to understand the relationship they have with the genesis of Alzheimer’s Disease. A UC bioengineering research team aims to provide a numerical model of the regulated blood supply with connected cells for the whole brain, which could model regulation of blood flow ...
SBHS’ Ready2Move Club Receives Fund for Santa Barbara’s Youth Making Change Grant for 2013 Week of Wellness, Brain ...
Tue, 12 Mar, 2013 11:07 AM PDT
High school health advocacy club provided by Sansum Diabetes Research Institute focuses on reducing obesity and preventing type 2 diabetes.
Drug reduces chest pain in patients with diabetes
Tue, 12 Mar, 2013 10:38 AM PDT
A commonly used anti-anginal drug reduces chest pain in patients with type 2 diabetes and appears to have a more pronounced effect in those with poorer glucose control, according to new research.
BUSM study reveals therapeutic targets to alter inflammation, type 2 diabetes
Tue, 12 Mar, 2013 10:07 AM PDT
( Boston University Medical Center ) New research from Boston University School of Medicine reveals that B cells regulate obesity-associated inflammation and type 2 diabetes through two specific mechanisms. The study, published in the Proceedings of the National Academy of Sciences, indicates the importance of continuing to explore B cells as a therapeutic target to treat these diseases.
Patents and Diagnostics
Tue, 12 Mar, 2013 09:48 AM PDT
Intellectual property claims may hinder using genomic tools for the betterment of public health, particularly for combating non-communicable diseases like type 2 diabetes, writes Anna George , an adjunct professor at Murdoch University in Australia and a Chatham House associate fellow, at the Guardian Professional . She estimates that about 20 percent of the human genome "is subject to patents ...
Center for Diabetes Education offers March 18 program
Tue, 12 Mar, 2013 09:42 AM PDT
WARWICK â€" The key to keeping blood glucose levels at your goal is to balance the food you eat with your physical activity and any pills or insulin you take.
Cellnovo Selects Flextronics As Manufacturing And Design Partner
Tue, 12 Mar, 2013 09:28 AM PDT
SAN JOSE, Calif. and SWANSEA, Wales, March 12, 2013 /PRNewswire/ -- Cellnovo, developer of the first mobile diabetes management system, and Flextronics (NASDAQ: FLEX), today announced that the two companies have entered into an agreement whereby Flextronics will manufacture and provide...

You received this email because you subscribed to Yahoo! Alerts. Use this link to unsubscribe from this alert. To change your communications preferences for other Yahoo! business lines, please visit your Marketing Preferences. To learn more about Yahoo!'s use of personal information, including the use of web beacons in HTML-based email, please read our Privacy Policy. Yahoo! is located at 701 First Avenue, Sunnyvale, CA 94089.

No comments:

Post a Comment